Novo Nordisk's Awiqli once-weekly basal insulin treatment approved by US FDA

Kodiak Sciences reports positive Phase 3 results for Zenkuda in diabetic retinopathy

Iterion Therapeutics reports first patient dosed in phase 1/2 trial of tegavivint in colorectal cancer

SciTech Development reports early-stage clinical data from Phase 1a trial of ST-001 nanoFenretinide at USCLC Annual Workshop 2026

Clarity Pharmaceuticals signs copper-64 manufacturing agreement with Theragenics

Merck to acquire Terns Pharmaceuticals for USD6.7bn

Maze Therapeutics reports positive Phase 2 data for MZE829 in patients with AMKD

Bio-Techne expands COMET spatial biology platform with new SPYRE Panels and Amplification Kits

CRISM Therapeutics advances Phase 2 glioblastoma trial with initial ChemoSeed batch manufactured

Myosin Therapeutics granted USD2m funding from Florida Department of Health

Clover Biopharmaceuticals reports positive US Phase I data for RSV re-vaccination in older adults

Hope Medicine reports first patient dosed in Phase III trial of HMI-115

Akeso's Phase II trials of AK146D1 and AK138D1 approved in China

Insilico Medicine and ASKA Pharmaceutical expand partnership on women's health targets

Sanofi and Regeneron's Dupixent gains Japan approval as first targeted therapy for bullous pemphigoid